Tag: Research
-
Center for Genetic Medicine Announces New Director for Transgenic and Targeted Mutagenesis Laboratory
Styliani (Stella) Markoulaki, PhD, has been named the new director of the Transgenic and Targeted Mutagenesis Laboratory.
-
Asian Americans’ Obesity Prevalence is not One-Size-Fits-All
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.
-
Novel Treatment Effective for Bladder Cancer, Study Shows in Mice
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.
-
Investigating the Role of Fatty Acids in Cancer Cell Survival
Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.
-
Northwestern Investigates COVID-19: Sentinel Surveillance, ‘Long COVID’ in Children
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
-
Study Identifies Mechanisms Promoting Bacterial Survival
Northwestern Medicine investigators have uncovered novel regulatory mechanisms that promote bacterial survival, according to findings published in PNAS.
-
Targeting Ion Channels to Manage Osteoarthritis Pain
Therapeutically targeting ion channels in nociceptor neurons may be a promising strategy for managing osteoarthritis pain, according to a Northwestern Medicine study.
-
Widespread Bias, Discrimination Directed Toward People With Disabilities Who Seek Healthcare
A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.
-
First Drug to Reduce Risk of Mortality and Hospitalization in Heart Failure
Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, reduced the risk of cardiovascular-related morality and hospitalization in patients with heart failure, regardless of ejection fraction, according to a series of clinical trial reports.
-
Advancing Lung Health Through Discovery-Based Research
Chronic lung disease is still the fourth leading cause of death in the U.S., making chronic lung disease both a research and clinical priority for many academic medical centers across the U.S. — including the Feinberg School of Medicine.
